Uncommon sense. April 2009

Similar documents
Marico - An Information Update January 28, 2010 Q3FY10 (Quarter ended December 31, 2009)

Marico - An Information Update October 28,2009 Q2FY10 (Quarter ended September 30, 2009)

Marico - Information Update for FY10 (Financial Year ended March 31, 2010)

Marico An Information Update for Q3FY11 (Quarter ended December 31, 2010)

Marico - An Information Update July 25, 2007 Q1FY08 (Quarter ended June 30, 2007)

Marico An Information Update for Q2FY11 (Quarter ended September 30, 2010)

Marico - An Information Update January 19, 2007 Q3FY07 (Quarter ended December 31, 2006)

Marico Information Update for Q4FY14 (Quarter ended March 31, 2014)

Marico An Information Update for Q1FY13 (Quarter ended June 30, 2012)

Marico. Source: Company Data; PL Research

Marico Information Update for Q1FY16 (Quarter ended June 30, 2015)

Marico Information Update for Q4FY15 (Quarter ended March 31, 2015)

Marico Information Update for Q1FY17 (Quarter ended June 30, 2016)

KRBL LIMITED. Investor Communication

Marico Information Update for Q2FY16 (Quarter ended September 30, 2015)

Marico Information Update for Q4FY16 (Quarter ended March 31, 2016)

Marico Ltd. Initiating Coverage. Key Investment Rationale PRICE : RS.68 TARGET PRICE : RS.90 FY09E PE : 19.2X

Marico Information Update for Q4FY17 (Quarter ended March 31, 2017)

MARICO LIMITED. Profit after Tax Add: Surplus brought forward

Marico Information Update for Q4FY18 (Quarter ended March 31, 2018)

B U I L D I N G T O L A S T

Investor Presentation February 2016

Hindustan Unilever Limited. SQ 18 Results Presentation : 12 th October 2018

Dabur India. CMP: INR130 TP: INR135 Neutral

Presentation at Citigroup Smith Barney India Corporate Day. London, June 2003

Marico Information Update for Q1FY18 (Quarter ended June 30, 2017)

INVESTOR PRESENTATION JANUARY Version -3

KESAR PETROPRODUCTS LIMITED

Hindustan Unilever Ltd.

DQ 14 Results Presentation January 19, 2015

Deutsche Bank Conference. Paris June 11th, 2007

INVESTOR PRESENTATION May 2018

BUY. BAJAJ CORP LIMITED Result Update: Q1 FY14. CMP (Rs) Target Price (Rs) AUGUST 10 th, 2013 HIGHLIGHTS

HOLD. Going aggressive in hair oils DABUR INDIA. Target Price: Rs 325. Key drivers (%) FY17 FY18E FY19E

Dabur India. CMP: INR106 TP: INR94 Neutral

HALF YEARLY REPORT MARICO BANGLADESH LIMITED

Hindustan Unilever Limited. MQ 18 & FY Results Presentation : 14 th May 2018

Avenue Supermarts Limited

Dabur India Limited Investor Presentation CLSA India Forum November 2018

SQ 14 Results Presentation October 27, 2014

Dabur India Limited. Investor Communication. Quarter and Half Year ended September 30, 2014

VOLTAS LTD PRICE: RS.154 RESULT UPDATE. Numbers are ahead of expectations on account of all-round margin expansion.

asianpaints a_-./ tl;r The aforesaid presentation will also be uploaded on the website of the Company 11' May, 2016 'I 1022)

Investor Communication. Quarter and Half Year ended 30 th September, 2016

MARICO LTD Result Update (CONSOLIDATED BASIS): Q4 FY18

Dabur India Limited Investor Communication

GODREJ CONSUMER PRODUCTS LIMITED 1Q FY2016 PERFORMANCE UPDATE

Dabur India Limited. Investor Presentation June 2018

Financials/Valu FY15 FY16 FY17 FY18E FY19E. Almond Drops Hair Oil (ADHO) volume declined by 7% YoY and 120 BAJAJCORP NIFTY

Aster DM Healthcare Ltd

Safe Harbor Statement

JM Financial India Conference. Mumbai

Marico (MARLIM) 255. Quarterly blip; growth story stays intact. Result Update. ICICI Securities Ltd Retail Equity Research.

ASTER DM HEALTHCARE LIMITED IPO Price Band : ` 180 `190. our recommendation avoid

Marico (MRCO IN) Copra price led margin expansion factored in. Company Report. Rating: ACCUMULATE CMP: Rs387 TP: Rs387. Channel checks Takeaways:

EARNINGS PRESENTATION 9M/Q3-FY2018

MQ 2015 & FY Results Presentation May 8, 2015

Dabur India Limited. Investor Communication. Quarter ended 30 th June August 4, 2017

INVESTOR PRESENTATION APRIL

Results SQ 10. October 26, Investor Presentation

Cravatex Limited. Stock Performance Details Shareholding Details September 2015

Presentation. 2013/14 Annual Results. 17 September 2014

S H Kelkar and Company Limited

Performance Update - 2Q FY16 October 24, 2015

Bajaj Corp Ltd Bloomberg Code: BJCOR IN

Narnolia Securities Ltd. RAJEEV ANAND 16-Oct-17

BSE Ltd (BSE) -New Initiatives to drive growth

Narnolia Securities Ltd. RAJEEV ANAND 15-Jan-18

DOLLAR INDUSTRIES LTD

Godrej Consumer Products

JQ 14 Results Presentation July 28, 2014

E A R N I N G S P R E S E N T A T I O N Q 3 & 9 M, F Y

GODREJ CONSUMER PRODUCTS INVESTOR PRESENTATION

Performance Update - 4Q FY16 May 3, 2016

Strong performance, delivering a record free cash flow Full Year Results 2012

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

CONSOLIDATED FINANCIALS

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

RESULTS FOR THE QUARTER ENDING 31 st MARCH % COMPARABLE* DOMESTIC CONSUMER GROWTH, 11% UNDERLYING VOLUME GROWTH

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

Welcome to Colgate-Palmolive India COLGATE-PALMOLIVE (INDIA) LIMITED ANALYST MEET OCT

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Unilever H Results

Dabur India Limited. Investor Presentation November December 2018

Dabur India. Institutional Equities. 1QFY19 Result Update

IPO NOTE AL MAHA CERAMICS SAOG (under transformation)

September Quarter 2015 Results Presentation October 14, 2015

Indian Oil Corporation Ltd.

Autoline Industries Ltd.

FY 16 IND-AS FINANCIALS

Mr. Vikas Oberoi honoured as best successor Second Generation at Hindustan Times Real Estate Awards

First Quarter FY15 Results Update

Q2/H1-FY18 EARNINGS PRESENTATION

PRESS RELEASE. Mumbai, January 27, 2016: Godrej Consumer Products Limited (GCPL), a leading

Business snapshot. ~50% of revenues comes from international businesses. Leading market share in home care, hair care and personal care

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

Welcome to Colgate-Palmolive India COLGATE-PALMOLIVE (INDIA) LIMITED ANALYST MEET MAY

Leadership in life insurance. April 2008

Performance and Outlook

Transcription:

Uncommon sense April 2009

Disclaimer This investor presentation has been prepared by Marico Limited ( Marico ) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be deemed to constitute an offer. No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its date. Certain statements made in this presentation may not be based on historical information or facts and may be forward looking statements, including those relating to the general business plans and strategy of Marico, its future financial condition and growth prospects, future developments in its industry and its competitive and regulatory environment, and statements which contain words or phrases such as will, expected to, horizons of growth, strong growth prospects, etc., or similar expressions or variations of such expressions. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results, opportunities and growth potential to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to risks with respect to its hair care, its healthcare business and its skin care business. Marico may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. This presentation cannot be copied and disseminated in any manner. No person is authorized to give any information or to make any representation not contained in and not consistent with this presentation and, if given or made, such information or representation must not be relied upon as having been authorized by or on behalf of Marico. This presentation is strictly confidential. 1

Sustained Profitable Growth 30,000 Strong Growth in Sales and Income (Rs. Mio) 25,000 20,000 15,000 10,000 5,000 11,439 CAGR 28% 15,569 19,067 23,884 Growth FY09 over FY08: 25% 0 FY06 FY07 FY08 FY 09 Growth from all businesses in FY09 Inflation led growth : 13% Organic volume Growth :12 % Inorganic Volume Growth : 1% 2 Source: Marico Annual Reports, Consolidated Financials for respective years

Sustained Profitable Growth EBITDA and EBITDA Margins 3,500 EBITDA EBITDA Margin 17.0% 3,000 15.0% (Rs. Mio) 2,500 2,000 1,500 1,000 500 12.6% 1,440 12.8% 1,986 12.9% 2,462 12.7% 3,012 13.0% 11.0% 9.0% 7.0% 0 FY06 FY07 FY08 FY 09 5.0% Margin band maintained in a year with high cost push Source: Marico Annual Reports, Consolidated Financials for respective years 3

Sundari Divestment Impact Marico Group One time PBT loss of Rs (15.03)crore Diminution is asset value in Sundari s books Tax shield on loss Rs 17.3 crore Net impact on PAT Rs 2.3 crore Marico Limited Standalone Provision for loans & interest Tax shield on loss Net impact on PAT Rs (47.8) crore Rs 17.3 crore Rs (30.5) crore Source: Marico Annual Reports, Consolidated Financials for respective years 4

Sustained Profitable Growth PAT before exceptional items 2000 1500 CAGR 29% Rs Mio 1000 500 869 1218 1542 1863 0 FY 2006 FY 2007 FY 2008 FY 2009 Growth FY09 over FY08: 21% 5

Sustained Profitable Growth Consistent Across Quarters * Sales and Services 34 consecutive quarters Since Q2 FY 01 Profit after Tax 38 consecutive quarters Since Q2 FY 00 * Growth in quarterly performance measured by comparing quarterly performance of the relevant quarter compared to similar quarterly period of the previous year 6

Coconut Oil Market Share PCNO 48% Nihar 6% OOM 1% Total CNO 55% FY09 Volume growth in rigid packs Parachute : 9% Nihar : 8% Loose, 1000 CNO Market (Rs Cr) Branded, 1500 Grow the branded market Conversion from loose to packed Micro Marketing Focus on smaller market segments Likely Medium Term Volume growth : 6% to 8% Market Share AC Nielsen 12 months ended Feb 2009 7

Hair Oil Marico FY04 17.8% 12 months ended February 09 22.2% Volume Growth (Rigids) FY09: 17% Shift from Loose Oil Higher incomes Higher frequency of usage Aim to gain market share Prototype of Nihar Naturals Coconut Cooling Oil Participate in Cooling Oils Segment Source: A.C.Nielsen All India Urban and Rural Market share for value added coconut oil, non-sticky hair oils, Amla and cooling oils 8

Post Wash Hair Care More Modern and Youth Products Currently small with modest growth Presence in category to leverage growth when it occurs 9

Saffola (Premium Refined Edible Oil) Strong Good for Heart positioning. Safflower Oil and its blends Volume Growth FY09 : 11% Introduced Saffola Active Exceptionally high premium to other brands H2FY09 Correction in premium in Q1 FY 10 Saffola Active at Rs 89, to bring more consumers into Saffola fold 10

From an edible oil to a Lifestyle Brand Riding a Healthcare Trend Low-Sodium Salt First in refined oil blends Edible Oil Functional Foods Space Lifestyle products 11

Strategic Funding On-going Prototypes to create a future pipeline of products Strategic funding is negative contribution after direct variable costs & ASP Company budgets for a % of profits for strategic funding each year. 12

New Product Pipeline Prototype Methodology Enables experimentation & de-risked growth Products Successfully Prototyped Saffola functional foods Cholesterol and Diabetes Management Atta Mix Revive Liquid Stiffener Parachute Advansed Starz - Cream Gel, Gentle Shampoo and non-sticky hair oil for kids Parachute Therapie Hair Fall Solution Parachute Advansed Revitalising Hot Oil 13

Current Prototypes Nihar Naturals Coconut Cooling Oil Revive Strong & White Saffola Rice Low GI rice for weight management Saffola Zest Healthy Baked (Not Fried) Snack 14

Modern Trade Currently about 6% of business Higher for Saffola and some new products Slowdown in store expansion Correction in overall inventory levels By and large no excessive delays in payments No large provisions required 15

Rural India Super-distributor sales ~ 25% of turnover Slightly higher margin & credit period New lower price point SKU in Parachute Some tweaking of ASP towards rural audience Rural thrust in select territories in FY10 16

International Business Group (IBG) Turnover (Rs mio) 5000 4000 3000 2000 1000 955 CAGR 45% 1171 1931 3068 4403 0 2004-05 2005-06 2006-07 2007-08 2008-09 Turbulent environment in FY09 High inflation / currency movements Growth in FY09-43%, including 15% owing to INR depreciation Turnover at 440 cr, now 18.4% of Group 17

IBG Bangladesh Marico Bangladesh FY09 turnover ~Rs 2 bn Parachute gaining market share steadily 73% (12 months ended February 2009) up from 67% on a year-on-year basis. Retail Reach ~ 3,70,000 Reach leveraged through new product introduction Hair Code hairdye Herbal hair dye 18

IBG - MENA GCC: Market share gains in hair creams & hair oils Commenced entry into new geographies Egypt: Changes made in supply chain structure Introduced distributors Led to revenue contraction in FY09 Transition completed Back on track for FY10 19

IBG South Africa Turnover in FY09 ~ Rs 500 million Smooth integration and Overall performance on track Caivil premium ethnic hair care brand restaged Hercules flavoured castor oil introduced FY10: New products prototypes and expansion in Southern Africa 20

Kaya Skin Care Solutions Turnover in FY09 Rs. 1.6 bn Growth of 57% Growth from clinics opened before Apr08 ~ 18% 85 Clinics 74 in India, 11 in the Middle East Added 20 clinics in FY 09 Customer base more than 500,000 Product revenue - 13% of Total FY 09 bottom-line Rs (160) mio Will turn positive in FY 10 21

Kaya Middle East Kaya clinics present in 11 centers 8 across UAE, 2 in Saudi Arabia and one in Oman Plans to open more clinics in these territories Current turnover at about Rs 410 million 22

Kaya Growth Clinic expansion 15 per year New catchment area for clinics Skin Zones (in malls) New Services & Products Kaya Care Annual membership program 23

Kaya Life Holistic Weight Management Sustainable weight loss Model being honed before scale up Four centers in Mumbai Juhu, Malad, Bandra and Vashi 24

Entrenched Brands Brand Category Indicative Market Share (%) # Rank Parachute Coconut Oil (India) ~ 48% 1 Parachute Coconut Oil (Bangladesh) ~ 73% 1 Saffola Refined Safflower Oil and its blends ~ 98% 1 Mediker Anti Lice Treatment ~ 90%* 1 Revive Instant Fabric Starch ~ 80%* 1 Parachute Jasmine, Shanti Amla, Hair & Care, Nihar Hair Oils ~ 22% 2 Dominant brand categories: Parachute, Saffola, Mediker Sector defining categories: Revive, Kaya * Company Estimates, # Market share data sourced from A.C. Nielsen for 12 month period ending March 2009 25

Q4 FY 09 at a glance Q4 FY 09 Q4 FY 08 (Rs Cr) (Rs Cr) % change Group Turnover 561 467 20% PBT adjusted for exceptional items 59 31 90% Net Profit adjusted for exceptional items 42 29 43% 26

Operating Margin % to Sales Q4 FY 09 Q4 FY 08 Material Cost (Raw + Packaging) 50.8% 50.8% Advertising & Sales Promotion (ASP) 10.1% 15.2% Personnel Costs 7.6% 7.8% Other Expenses 18.4% 16.5% PBDIT 13.1% 9.6% Gross Margin (PBDIT before ASP) 23.2% 25.0% 27

Capital Expenditure & Funding 3 years Capex for Kaya Rs 500 million Normal Capex Rs 500 million Debt at present Rs 3.8 billion (Net Debt Rs 2.7 billion) Operating cash flows sufficient to service this debt Acquisitions??? To maintain quantum of dividend, reduce payout %. Fresh equity only if a large acquisition opportunity is available 28

Performance in Numbers FY06 FY07 FY08 FY 09 (Rs. crore, except ratios) Sales/ Services Income 1,144 1,557 1,905 2,388 EBITDA 144 199 246 301 Net Profit after Tax 87 113 169 189 Equity Capital 58 60.9 60.9 60.9 Net worth 261 192 315 453 EPS (Rs.) 1.5 1.9 2.8 3.1 EBITDA Margin (%) 12.6 12.8 12.9 12.7 PAT Margin (%) 7.6 7.3 8.9 7.9 Source: Marico Annual Reports, Consolidated Financials for respective years 29

RM Input Outlook Copra & safflower likely to be lower than FY09 Copra higher MSP announced by Government May limit the decline, but unlikely to raise average market rate to MSP level Crude oil based derivatives could be lower than in FY09 Liquid paraffin / HDPE 30

Outlook Focus on maintaining growth momentum ~10% in volume terms Likely to be higher in Kaya & IBG IBG can vary based on INR movement vs. multiple currencies Margin expansion aided by lower input costs Continue to invest in established and new brands / territories No significant change in competitive landscape 31

Recognition in all spheres of business Rated India s one of most innovative companies (BT 2008) Ramkrishna Bajaj Award for Quality Jalgaon wins CII award for Water Management Asia Star Award for Parachute Packaging innovation Kaya wins Star retailer Award 08 32

Recognition in all spheres of business Saffola continues EFFIE winning streak also adds EMVIE & ABBY to its kitty Marico Corporate Brand: Clean Sweep at Remmies Bangladesh: Parachute becomes 6th most trusted brand Marico wins Economic Times Smart Workplace Award SPJIMR Award for IT in Sales 33

Thank You